The EPA issues proposed rules placing limits on the use of ethylene oxide as a sterilizing agent and adopting related record keeping and worker safety requirements; the owner of DME supply companies pleads guilty to conspiracy to commit health care fraud for paying a marketing company for medically unnecessary DME orders procured through telemedicine encounters that were allegedly medically unjustified; the FDA issues Q&A guidance regarding a risk-based approach to monitoring clinical investigations.